 | • レポートコード：D0804-14819 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、105ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、自己免疫疾患治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。自己免疫疾患治療薬の種類別市場規模（NSAIDs、抗炎症剤、インターフェロン、血糖降下剤、その他）、用途別市場規模（関節リウマチ、1型糖尿病、多発性硬化症、乾癬、ループス、炎症性腸疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott Laboratories、Roche、Eli Lilly、Pfizer、GlaxoSmithKline、AbbVie、Amgen、AstraZeneca plc、Bristol-Myers Squibb、Biogen ・地域別グローバル市場分析 2015年-2020年 ・自己免疫疾患治療薬の北米市場（アメリカ、カナダ、メキシコ） ・自己免疫疾患治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・自己免疫疾患治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・自己免疫疾患治療薬の南米市場（ブラジル、アルゼンチン） ・自己免疫疾患治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：NSAIDs、抗炎症剤、インターフェロン、血糖降下剤、その他 ・用途別分析：関節リウマチ、1型糖尿病、多発性硬化症、乾癬、ループス、炎症性腸疾患、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Autoimmune Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Autoimmune Disease Drug sales will be xx in 2020 from Autoimmune Disease Drug million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Autoimmune Disease Drug market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Autoimmune Disease Drug industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Autoimmune Disease Drug and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Autoimmune Disease Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Autoimmune Disease Drug market has been segmented into:
NSAIDs
Anti-Inflammatory
Interferons
Antihyperglycemics
Others
By Application, Autoimmune Disease Drug has been segmented into:
Rheumatoid Arthritis
Type 1 Diabetes
Multiple Sclerosis
Psoriasis
Lupus
Inflammatory Bowel Disease
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Autoimmune Disease Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Autoimmune Disease Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Autoimmune Disease Drug market.
The report offers in-depth assessment of the growth and other aspects of the Autoimmune Disease Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Autoimmune Disease Drug Market Share Analysis
Autoimmune Disease Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Autoimmune Disease Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Autoimmune Disease Drug sales, revenue and market share for each player covered in this report.
The major players covered in Autoimmune Disease Drug are:
Abbott Laboratories
Roche
Eli Lilly
Pfizer
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca plc
Bristol-Myers Squibb
Biogen
Among other players domestic and global, Autoimmune Disease Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Autoimmune Disease Drug Market Overview
1.1 Product Overview and Scope of Autoimmune Disease Drug
1.2 Classification of Autoimmune Disease Drug by Type
1.2.1 Global Autoimmune Disease Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Autoimmune Disease Drug Revenue Market Share by Type in 2019
1.2.3 NSAIDs
1.2.4 Anti-Inflammatory
1.2.5 Interferons
1.2.6 Antihyperglycemics
1.2.7 Others
1.3 Global Autoimmune Disease Drug Market by Application
1.3.1 Overview: Global Autoimmune Disease Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Rheumatoid Arthritis
1.3.3 Type 1 Diabetes
1.3.4 Multiple Sclerosis
1.3.5 Psoriasis
1.3.6 Lupus
1.3.7 Inflammatory Bowel Disease
1.3.8 Others
1.4 Global Autoimmune Disease Drug Market by Regions
1.4.1 Global Autoimmune Disease Drug Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Autoimmune Disease Drug (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Autoimmune Disease Drug Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Autoimmune Disease Drug Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Autoimmune Disease Drug Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Autoimmune Disease Drug Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Autoimmune Disease Drug Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Autoimmune Disease Drug Industry Impact
1.5.1 COVID-19 Potential Implications for the Autoimmune Disease Drug
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Autoimmune Disease Drug
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Roche SWOT Analysis
2.2.4 Roche Product and Services
2.2.5 Roche Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eli Lilly SWOT Analysis
2.3.4 Eli Lilly Product and Services
2.3.5 Eli Lilly Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GlaxoSmithKline SWOT Analysis
2.5.4 GlaxoSmithKline Product and Services
2.5.5 GlaxoSmithKline Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.6 AbbVie
2.6.1 AbbVie Details
2.6.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AbbVie Product and Services
2.6.4 AbbVie Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Amgen Product and Services
2.7.4 Amgen Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.8 AstraZeneca plc
2.8.1 AstraZeneca plc Details
2.8.2 AstraZeneca plc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 AstraZeneca plc Product and Services
2.8.4 AstraZeneca plc Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bristol-Myers Squibb
2.9.1 Bristol-Myers Squibb Details
2.9.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bristol-Myers Squibb Product and Services
2.9.4 Bristol-Myers Squibb Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
2.10 Biogen
2.10.1 Biogen Details
2.10.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Biogen Product and Services
2.10.4 Biogen Autoimmune Disease Drug Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Autoimmune Disease Drug Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Autoimmune Disease Drug Players Market Share
3.2.2 Top 10 Autoimmune Disease Drug Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Autoimmune Disease Drug Revenue and Market Share by Regions
4.2 North America Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
4.3 Europe Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
4.5 South America Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
5 North America Autoimmune Disease Drug Revenue by Countries
5.1 North America Autoimmune Disease Drug Revenue by Countries (2015-2020)
5.2 USA Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
5.3 Canada Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
5.4 Mexico Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
6 Europe Autoimmune Disease Drug Revenue by Countries
6.1 Europe Autoimmune Disease Drug Revenue by Countries (2015-2020)
6.2 Germany Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
6.3 UK Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
6.4 France Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
6.5 Russia Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
6.6 Italy Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Autoimmune Disease Drug Revenue by Countries
7.1 Asia-Pacific Autoimmune Disease Drug Revenue by Countries (2015-2020)
7.2 China Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
7.3 Japan Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
7.4 Korea Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
7.5 India Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
8 South America Autoimmune Disease Drug Revenue by Countries
8.1 South America Autoimmune Disease Drug Revenue by Countries (2015-2020)
8.2 Brazil Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
8.3 Argentina Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Autoimmune Disease Drug by Countries
9.1 Middle East & Africa Autoimmune Disease Drug Revenue by Countries (2015-2020)
9.2 Saudi Arabia Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
9.3 UAE Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
9.4 Egypt Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
9.5 South Africa Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Autoimmune Disease Drug Revenue and Market Share by Type (2015-2020)
10.2 Global Autoimmune Disease Drug Market Forecast by Type (2019-2024)
10.3 NSAIDs Revenue Growth Rate (2015-2025)
10.4 Anti-Inflammatory Revenue Growth Rate (2015-2025)
10.5 Interferons Revenue Growth Rate (2015-2025)
10.6 Antihyperglycemics Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global Autoimmune Disease Drug Market Segment by Application
11.1 Global Autoimmune Disease Drug Revenue Market Share by Application (2015-2020)
11.2 Autoimmune Disease Drug Market Forecast by Application (2019-2024)
11.3 Rheumatoid Arthritis Revenue Growth (2015-2020)
11.4 Type 1 Diabetes Revenue Growth (2015-2020)
11.5 Multiple Sclerosis Revenue Growth (2015-2020)
11.6 Psoriasis Revenue Growth (2015-2020)
11.7 Lupus Revenue Growth (2015-2020)
11.8 Inflammatory Bowel Disease Revenue Growth (2015-2020)
11.9 Others Revenue Growth (2015-2020)
12 Global Autoimmune Disease Drug Market Size Forecast (2021-2025)
12.1 Global Autoimmune Disease Drug Market Size Forecast (2021-2025)
12.2 Global Autoimmune Disease Drug Market Forecast by Regions (2021-2025)
12.3 North America Autoimmune Disease Drug Revenue Market Forecast (2021-2025)
12.4 Europe Autoimmune Disease Drug Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Autoimmune Disease Drug Revenue Market Forecast (2021-2025)
12.6 South America Autoimmune Disease Drug Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Autoimmune Disease Drug Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Autoimmune Disease Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Autoimmune Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Autoimmune Disease Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Autoimmune Disease Drug Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Autoimmune Disease Drug Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Abbott Laboratories Corporate Information, Location and Competitors
Table 7. Abbott Laboratories Autoimmune Disease Drug Major Business
Table 8. Abbott Laboratories Autoimmune Disease Drug Total Revenue (USD Million) (2017-2018)
Table 9. Abbott Laboratories SWOT Analysis
Table 10. Abbott Laboratories Autoimmune Disease Drug Product and Solutions
Table 11. Abbott Laboratories Autoimmune Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Roche Corporate Information, Location and Competitors
Table 13. Roche Autoimmune Disease Drug Major Business
Table 14. Roche Autoimmune Disease Drug Total Revenue (USD Million) (2018-2019)
Table 15. Roche SWOT Analysis
Table 16. Roche Autoimmune Disease Drug Product and Solutions
Table 17. Roche Autoimmune Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Eli Lilly Corporate Information, Location and Competitors
Table 19. Eli Lilly Autoimmune Disease Drug Major Business
Table 20. Eli Lilly Autoimmune Disease Drug Total Revenue (USD Million) (2017-2018)
Table 21. Eli Lilly SWOT Analysis
Table 22. Eli Lilly Autoimmune Disease Drug Product and Solutions
Table 23. Eli Lilly Autoimmune Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Pfizer Corporate Information, Location and Competitors
Table 25. Pfizer Autoimmune Disease Drug Major Business
Table 26. Pfizer Autoimmune Disease Drug Total Revenue (USD Million) (2017-2018)
Table 27. Pfizer SWOT Analysis
Table 28. Pfizer Autoimmune Disease Drug Product and Solutions
Table 29. Pfizer Autoimmune Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. GlaxoSmithKline Corporate Information, Location and Competitors
Table 31. GlaxoSmithKline Autoimmune Disease Drug Major Business
Table 32. GlaxoSmithKline Autoimmune Disease Drug Total Revenue (USD Million) (2017-2018)
Table 33. GlaxoSmithKline SWOT Analysis
Table 34. GlaxoSmithKline Autoimmune Disease Drug Product and Solutions
Table 35. GlaxoSmithKline Autoimmune Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. AbbVie Corporate Information, Location and Competitors
Table 37. AbbVie Autoimmune Disease Drug Major Business
Table 38. AbbVie Autoimmune Disease Drug Total Revenue (USD Million) (2017-2018)
Table 39. AbbVie SWOT Analysis
Table 40. AbbVie Autoimmune Disease Drug Product and Solutions
Table 41. AbbVie Autoimmune Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Amgen Corporate Information, Location and Competitors
Table 43. Amgen Autoimmune Disease Drug Major Business
Table 44. Amgen Autoimmune Disease Drug Total Revenue (USD Million) (2017-2018)
Table 45. Amgen SWOT Analysis
Table 46. Amgen Autoimmune Disease Drug Product and Solutions
Table 47. Amgen Autoimmune Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. AstraZeneca plc Corporate Information, Location and Competitors
Table 49. AstraZeneca plc Autoimmune Disease Drug Major Business
Table 50. AstraZeneca plc Autoimmune Disease Drug Total Revenue (USD Million) (2017-2018)
Table 51. AstraZeneca plc SWOT Analysis
Table 52. AstraZeneca plc Autoimmune Disease Drug Product and Solutions
Table 53. AstraZeneca plc Autoimmune Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 55. Bristol-Myers Squibb Autoimmune Disease Drug Major Business
Table 56. Bristol-Myers Squibb Autoimmune Disease Drug Total Revenue (USD Million) (2017-2018)
Table 57. Bristol-Myers Squibb SWOT Analysis
Table 58. Bristol-Myers Squibb Autoimmune Disease Drug Product and Solutions
Table 59. Bristol-Myers Squibb Autoimmune Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Biogen Corporate Information, Location and Competitors
Table 61. Biogen Autoimmune Disease Drug Major Business
Table 62. Biogen Autoimmune Disease Drug Total Revenue (USD Million) (2017-2018)
Table 63. Biogen SWOT Analysis
Table 64. Biogen Autoimmune Disease Drug Product and Solutions
Table 65. Biogen Autoimmune Disease Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Global Autoimmune Disease Drug Revenue (Million USD) by Players (2015-2020)
Table 67. Global Autoimmune Disease Drug Revenue Share by Players (2015-2020)
Table 68. Global Autoimmune Disease Drug Revenue (Million USD) by Regions (2015-2020)
Table 69. Global Autoimmune Disease Drug Revenue Market Share by Regions (2015-2020)
Table 70. North America Autoimmune Disease Drug Revenue by Countries (2015-2020)
Table 71. North America Autoimmune Disease Drug Revenue Market Share by Countries (2015-2020)
Table 72. Europe Autoimmune Disease Drug Revenue (Million USD) by Countries (2015-2020)
Table 73. Asia-Pacific Autoimmune Disease Drug Revenue (Million USD) by Countries (2015-2020)
Table 74. South America Autoimmune Disease Drug Revenue by Countries (2015-2020)
Table 75. South America Autoimmune Disease Drug Revenue Market Share by Countries (2015-2020)
Table 76. Middle East and Africa Autoimmune Disease Drug Revenue (Million USD) by Countries (2015-2020)
Table 77. Middle East and Africa Autoimmune Disease Drug Revenue Market Share by Countries (2015-2020)
Table 78. Global Autoimmune Disease Drug Revenue (Million USD) by Type (2015-2020)
Table 79. Global Autoimmune Disease Drug Revenue Share by Type (2015-2020)
Table 80. Global Autoimmune Disease Drug Revenue Forecast by Type (2021-2025)
Table 81. Global Autoimmune Disease Drug Revenue by Application (2015-2020)
Table 82. Global Autoimmune Disease Drug Revenue Share by Application (2015-2020)
Table 83. Global Autoimmune Disease Drug Revenue Forecast by Application (2021-2025)
Table 84. Global Autoimmune Disease Drug Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Autoimmune Disease Drug Picture
Figure 2. Global Autoimmune Disease Drug Revenue Market Share by Type in 2019
Figure 3. NSAIDs Picture
Figure 4. Anti-Inflammatory Picture
Figure 5. Interferons Picture
Figure 6. Antihyperglycemics Picture
Figure 7. Others Picture
Figure 8. Autoimmune Disease Drug Revenue Market Share by Application in 2019
Figure 9. Rheumatoid Arthritis Picture
Figure 10. Type 1 Diabetes Picture
Figure 11. Multiple Sclerosis Picture
Figure 12. Psoriasis Picture
Figure 13. Lupus Picture
Figure 14. Inflammatory Bowel Disease Picture
Figure 15. Others Picture
Figure 16. Global Autoimmune Disease Drug Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. North America Autoimmune Disease Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Europe Autoimmune Disease Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Asia-Pacific Autoimmune Disease Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. South America Autoimmune Disease Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Middle East and Africa Autoimmune Disease Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Autoimmune Disease Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Global Autoimmune Disease Drug Revenue Share by Players in 2019
Figure 24. Global Top 5 Players Autoimmune Disease Drug Revenue Market Share in 2019
Figure 25. Global Top 10 Players Autoimmune Disease Drug Revenue Market Share in 2019
Figure 26. Key Players Market Share Trend
Figure 27. Global Autoimmune Disease Drug Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 28. Global Autoimmune Disease Drug Revenue Market Share by Regions (2015-2020)
Figure 29. Global Autoimmune Disease Drug Revenue Market Share by Regions in 2018
Figure 30. North America Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 31. Europe Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 32. Asia-Pacific Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 33. South America Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 34. Middle East and Africa Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 35. North America Autoimmune Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 36. North America Autoimmune Disease Drug Revenue Market Share by Countries in 2019
Figure 37. USA Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 38. Canada Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 39. Mexico Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 40. Europe Autoimmune Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 41. Europe Autoimmune Disease Drug Revenue Market Share by Countries in 2019
Figure 42. Germany Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 43. UK Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 44. France Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 45. Russia Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 46. Italy Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Autoimmune Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 48. Asia-Pacific Autoimmune Disease Drug Revenue Market Share by Countries in 2019
Figure 49. China Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 50. Japan Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 51. Korea Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 52. India Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 53. Southeast Asia Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 54. South America Autoimmune Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 55. South America Autoimmune Disease Drug Revenue Market Share by Countries in 2019
Figure 56. Brazil Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 57. Argentina Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 58. Middle East and Africa Autoimmune Disease Drug Revenue Market Share by Countries (2015-2020)
Figure 59. Middle East and Africa Autoimmune Disease Drug Revenue Market Share by Countries in 2019
Figure 60. Saudi Arabia Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 61. UAE Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 62. Egypt Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 63. South Africa Autoimmune Disease Drug Revenue and Growth Rate (2015-2020)
Figure 64. Global Autoimmune Disease Drug Revenue Share by Type (2015-2020)
Figure 65. Global Autoimmune Disease Drug Revenue Share by Type in 2019
Figure 66. Global Autoimmune Disease Drug Market Share Forecast by Type (2021-2025)
Figure 67. Global NSAIDs Revenue Growth Rate (2015-2020)
Figure 68. Global Anti-Inflammatory Revenue Growth Rate (2015-2020)
Figure 69. Global Interferons Revenue Growth Rate (2015-2020)
Figure 70. Global Antihyperglycemics Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Autoimmune Disease Drug Revenue Share by Application (2015-2020)
Figure 73. Global Autoimmune Disease Drug Revenue Share by Application in 2019
Figure 74. Global Autoimmune Disease Drug Market Share Forecast by Application (2021-2025)
Figure 75. Global Rheumatoid Arthritis Revenue Growth Rate (2015-2020)
Figure 76. Global Type 1 Diabetes Revenue Growth Rate (2015-2020)
Figure 77. Global Multiple Sclerosis Revenue Growth Rate (2015-2020)
Figure 78. Global Psoriasis Revenue Growth Rate (2015-2020)
Figure 79. Global Lupus Revenue Growth Rate (2015-2020)
Figure 80. Global Inflammatory Bowel Disease Revenue Growth Rate (2015-2020)
Figure 81. Global Others Revenue Growth Rate (2015-2020)
Figure 82. Global Autoimmune Disease Drug Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 83. Global Autoimmune Disease Drug Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 84. Global Autoimmune Disease Drug Revenue Market Share Forecast by Regions (2021-2025)
Figure 85. North America Autoimmune Disease Drug Revenue Market Forecast (2021-2025)
Figure 86. Europe Autoimmune Disease Drug Revenue Market Forecast (2021-2025)
Figure 87. Asia-Pacific Autoimmune Disease Drug Revenue Market Forecast (2021-2025)
Figure 88. South America Autoimmune Disease Drug Revenue Market Forecast (2021-2025)
Figure 89. Middle East and Africa Autoimmune Disease Drug Revenue Market Forecast (2021-2025)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
自己免疫疾患治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Autoimmune Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.3% in the forecast period of 2020 to 2025 and will expected to reach USD 111090 million by 2025, from USD 101510 million in 2019. The Autoimm…- 自己免疫疾患診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Autoimmune Disease Diagnosis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.8% in the forecast period of 2020 to 2025 and will expected to reach USD 3707.6 million by 2025, from USD 3070.2 million in 2019. The Autoimm…
- 希少疾患治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Rare Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Rare Disease Drug market re…
- 小児呼吸器疾患治療の世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Pediatric Respiratory Disease Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, valu…
- タンパク質電気泳動の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Protein Electrophoresis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Protein Electrophores…